Does TRIMETHOPRIM Cause Bladder transitional cell carcinoma? 12 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Bladder transitional cell carcinoma have been filed in association with TRIMETHOPRIM (Trimethoprim). This represents 0.4% of all adverse event reports for TRIMETHOPRIM.
12
Reports of Bladder transitional cell carcinoma with TRIMETHOPRIM
0.4%
of all TRIMETHOPRIM reports
0
Deaths
12
Hospitalizations
How Dangerous Is Bladder transitional cell carcinoma From TRIMETHOPRIM?
Of the 12 reports, 12 (100.0%) required hospitalization.
Is Bladder transitional cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRIMETHOPRIM. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does TRIMETHOPRIM Cause?
Headache (409)
Nausea (383)
Off label use (376)
Drug ineffective (368)
Malaise (346)
Swelling face (267)
Hypersensitivity (260)
Acute kidney injury (249)
Rash (235)
Drug intolerance (231)
What Other Drugs Cause Bladder transitional cell carcinoma?
PIOGLITAZONE (398)
ADALIMUMAB (96)
METHOTREXATE (95)
RITUXIMAB (74)
TOCILIZUMAB (68)
INFLIXIMAB (63)
SULFASALAZINE (55)
HYDROXYCHLOROQUINE (50)
PREDNISONE (48)
LENALIDOMIDE (42)
Which TRIMETHOPRIM Alternatives Have Lower Bladder transitional cell carcinoma Risk?
TRIMETHOPRIM vs TRIMIPRAMINE
TRIMETHOPRIM vs TRIPROLIDINE
TRIMETHOPRIM vs TRIPTORELIN
TRIMETHOPRIM vs TRISODIUM
TRIMETHOPRIM vs TROFINETIDE